News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Ramps Up Vaccines Drive With $39 Million Chinese Buyout



6/14/2011 8:16:32 AM

GlaxoSmithKline (GSK.L) is to buy out its partner in a Chinese flu vaccine joint venture, in a move to expand its vaccines presence in a key emerging market. The drugmaker said on Tuesday it would pay 24 million pounds ($39 million) to acquire the remaining 51 percent stake held by Shenzhen Neptunus Interlong Bio-Technique (8329.HK) in the joint company, Shenzhen GSK-Neptunus Biologicals (GSKNB).

Read at Reuters
Read at Wall Street Journal
Read at Fox News
Read at This Is London [U.K.]
Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES